Abstract
KC-144, an iodine–lithium complex, counters cisplatin resistance in PM by tipping mitochondrial redox balance, triggering Δψm loss, ROS rise, G0/G1 shift, and strong suppression of clonogenic survival.
Comparative Antitumor and Mechanistic Effects of the Iodine–Lithium Complex KC-144 in Cisplatin-Sensitive, Cisplatin-Resistant and Non-Malignant Mesothelial Cells
2026
DOI 10.30919/es2033
How this score is calculated
It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.